St. James's Place Capital PLC
31 October 2001
PRESS RELEASE
31 October 2001
New Business Figures for nine months ended 30 September 2001
St. James's Place Capital plc ('SJPC'), the wealth management group, today
announces its new business figures for the nine months ending 30 September
2001.
The text of the announcement is attached:
Enquiries:
Mike Wilson, Chief Executive Tel: 020 7514 1907
Nitya Bolam, Brunswick Tel: 020 7404 5959
ST. JAMES'S PLACE GROUP
NEW BUSINESS FIGURES
UP 16% FOR NINE MONTHS ENDED 30 SEPTEMBER 2001
* SJPC - the wealth management group - today announces its new business
results for the nine months ended 30 September 2001.
Highlights for the nine months and changes over 2000 were:
New Regular Premiums
Life £17.2m +4%
Pension £35.0m +36%
Total £52.2m +23%
New Single Premiums
Life £582.7m +8%
Pension £167.0m +120%
Total £749.7m +22%
New Unit Trust Sales
(includes PEPs and ISAs) £251.2m -8%
Total New Business £152.3m +16%
Mike Wilson, Group Chief Executive, commented:
'We are very pleased with the 16% growth in our new business despite difficult
market conditions. Life and Pensions sales increased by 23% demonstrating the
adaptability and the resilience of the St. James's Place Partnership.'
ST. JAMES'S PLACE GROUP
NEW BUSINESS FIGURES
FOR NINE MONTHS TO 30 SEPTEMBER 2001
Unaudited Unaudited
3 Months to 9 Months to
30 September 2001 30 September 2001
Total Group Business 2001 2000 Growth 2001 2000 Growth
(Excluding
International)
£'m £'m % £'m £'m %
Life and Pension
Business
New Regular Premiums
Life 6.0 5.5 9% 17.2 16.6 4%
Pension 8.2 8.5 (4%) 35.0 25.8 36%
14.2 14.0 1% 52.2 42.4 23%
New Single Premiums
Life 174.4 183.7 (5%) 582.7 537.3 8%
Pension 74.0 30.4 143% 167.0 76.0 120%
248.4 214.1 16% 749.7 613.3 22%
Unit Trust Business
(including PEPs and
ISAs)
New Single Premiums 63.7 72.7 (12%) 251.2 273.5 (8%)
Total New Business
Life 23.4 23.9 (2%) 75.5 70.3 7%
Pension 15.6 11.5 36% 51.7 33.4 55%
Unit Trust 6.4 7.3 (12%) 25.1 27.4 (8%)
45.4 42.7 6% 152.3 131.1 16%
ST. JAMES'S PLACE GROUP
NEW BUSINESS FIGURES
FOR NINE MONTHS TO 30 SEPTEMBER 2001
Notes to Editors
1. 'Total New Business' is calculated following the convention in the life
assurance industry, by adding together new regular premiums and one-tenth of
single premiums and unit trust sales.
2. Funds under management were £5.5 billion, down 4% since the year end.
3. New business indicator (NBI), the measure used internally to equate the
relative value of different classes of business, was £46.6 million, up 9% on
2000.
4. Sales of Stakeholder pensions through Clerical Medical by St. James's Place
Partnership have been included in the reported figures. These have been
included under 'pensions' and amount to £4.3 million regular premiums and £
1.7 million single premiums (equivalent to £4.5 million on a Total New
Business basis).
5. Sales from Nascent, the Group's joint venture company in Italy, have been
excluded from the reported figures. Nascent made investment sales during
the nine months ending 30 September 2001 of £79.6 million, of which £25.4
million related to products of other fund management firms. At the end of
the period Nascent had 158 sales people under contract.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.